Narjust Florez: Stay tuned for a discussion on lung cancer data presented at ASCO24
Narjust Florez shared a post on X:
“Stay tuned for an incredible discussion about the lung cancer data presented at ASCO24 – Part 1 of 2!
With our plenary speakers Drs. Lecia Sequist and David R. Spigel
Only in Lung Cancer Considered, the official IASLC podcast with my co-host Dr. Stephen V Liu.”
Source: Narjust Florez/X
Narjust Florez is the Associate Director of the Cancer Care Equity Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.
She received the 2020 Rising Star award by the LEAD National Conference for women in hematology and oncology. In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023